D.E. Shaw & Co’s Sharps Compliance Corp SMED Stock Holding History

D.E. Shaw & Co’s Portfolio SMED Stock Details SMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-43,849	Closed	-$452K	–	5494
2021 Q2	$452K	Buy	+43,849	New	+$610K	﹤0.01%	4086

Other funds holding SMED

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

D.E. Shaw & Co's SMED Position: Q3 2021 in Review

D.E. Shaw & Co sold out of Sharps Compliance Corp (SMED) in Q3 2021, closing a stake of 43,849 shares — an estimated $452K sold.

D.E. Shaw & Co first reported a position in SMED in Q2 2021 and held it in 1 quarter. The position peaked at $452K in Q2 2021. 79 funds tracked by Wall St. Rank hold SMED as of Q3 2021.

D.E. Shaw & Co reported no remaining Sharps Compliance Corp position as of Q3 2021 after selling out during the quarter.
D.E. Shaw & Co sold 43,849 Sharps Compliance Corp shares in Q3 2021, an estimated $452K.
D.E. Shaw & Co first reported a position in Sharps Compliance Corp in Q2 2021 and held it in 1 quarter.
D.E. Shaw & Co's Sharps Compliance Corp position peaked at $452K in Q2 2021.
79 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q3 2021.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.